Guido Hanauer

1.5k total citations
22 papers, 602 citations indexed

About

Guido Hanauer is a scholar working on Surgery, Molecular Biology and Pharmacology. According to data from OpenAlex, Guido Hanauer has authored 22 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Guido Hanauer's work include Helicobacter pylori-related gastroenterology studies (7 papers), Phosphodiesterase function and regulation (4 papers) and Gastroesophageal reflux and treatments (3 papers). Guido Hanauer is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (7 papers), Phosphodiesterase function and regulation (4 papers) and Gastroesophageal reflux and treatments (3 papers). Guido Hanauer collaborates with scholars based in Germany, Switzerland and United States. Guido Hanauer's co-authors include S. Schreiber, H. O. Werling, Christine Josenhans, Sebastian Suerbaum, Peter Scheid, Klaus Melchers, George Sachs, Stefan Postius, Angela Schmidt and Wolfgang Simon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and The FASEB Journal.

In The Last Decade

Guido Hanauer

22 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido Hanauer Germany 9 310 222 148 90 84 22 602
Thomas G. Verriere United States 13 206 0.7× 356 1.6× 233 1.6× 48 0.5× 40 0.5× 15 739
György Miklós Buzás Hungary 12 341 1.1× 145 0.7× 71 0.5× 110 1.2× 113 1.3× 58 542
B. Kollberg Sweden 15 397 1.3× 91 0.4× 37 0.3× 93 1.0× 139 1.7× 30 821
Christoph von Ritter Germany 16 394 1.3× 135 0.6× 125 0.8× 265 2.9× 159 1.9× 21 890
Jianyi Yin United States 17 165 0.5× 301 1.4× 45 0.3× 99 1.1× 68 0.8× 32 844
Radosław Kempiński Poland 13 147 0.5× 103 0.5× 72 0.5× 28 0.3× 48 0.6× 34 461
Yuan‐Chieh Yang Taiwan 11 184 0.6× 86 0.4× 38 0.3× 45 0.5× 49 0.6× 21 382
José Luis Realpe United States 11 851 2.7× 143 0.6× 297 2.0× 362 4.0× 129 1.5× 15 1.1k
Ami Ben Yaʼacov Israel 19 176 0.6× 219 1.0× 328 2.2× 15 0.2× 11 0.1× 39 883
Stefan Postius Germany 14 461 1.5× 196 0.9× 79 0.5× 88 1.0× 193 2.3× 34 703

Countries citing papers authored by Guido Hanauer

Since Specialization
Citations

This map shows the geographic impact of Guido Hanauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Hanauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Hanauer more than expected).

Fields of papers citing papers by Guido Hanauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Hanauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Hanauer. The network helps show where Guido Hanauer may publish in the future.

Co-authorship network of co-authors of Guido Hanauer

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Hanauer. A scholar is included among the top collaborators of Guido Hanauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Hanauer. Guido Hanauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nio, Yasunori, et al.. (2021). Protective effect of a novel phosphodiesterase 4 selective inhibitor, compound A, in diabetic nephropathy model mice. European Journal of Pharmacology. 894. 173852–173852. 6 indexed citations
2.
Nio, Yasunori, Guido Hanauer, Kimio Tohyama, et al.. (2020). Ameliorative effect of phosphodiesterase 4 and 5 inhibitors in deoxycorticosterone acetate‐salt hypertensive uni‐nephrectomized KKA y mice. The FASEB Journal. 34(11). 14997–15014. 5 indexed citations
3.
Rabe, Klaus F., Henrik Watz, Simonetta Baraldo, et al.. (2018). Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial. The Lancet Respiratory Medicine. 6(11). 827–836. 42 indexed citations
4.
Plock, Nele, et al.. (2017). Pharmacokinetic/Pharmacodynamic Modeling of the PDE4 Inhibitor TAK‐648 in Type 2 Diabetes: Early Translational Approaches for Human Dose Prediction. Clinical and Translational Science. 10(3). 185–193. 9 indexed citations
5.
Christenson, Stephanie A., Samaneh Bolourchi, Gary B. Huffnagle, et al.. (2017). Molecular phenotyping of chronic bronchitis: mucin and inflammatory gene expression heterogeneity in COPD. PA1019–PA1019. 1 indexed citations
6.
Mann, Klaus, Guido Hanauer, Claude Ostermann, et al.. (2012). Structure–activity relationships of 2-arylamido-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxamide derivatives as cannabinoid receptor agonists and their analgesic action. Bioorganic & Medicinal Chemistry Letters. 22(24). 7314–7321. 7 indexed citations
7.
Hanauer, Guido, et al.. (2012). The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db/db mice. Diabetologia. 55(10). 2779–2788. 51 indexed citations
8.
Hanauer, Guido, et al.. (2007). VALIDATION OF RESPIRATORY PARAMETERS IN RATS USING WHOLE-BODY PLETHYSMOGRAPHY. Journal of Pharmacological and Toxicological Methods. 56(2). e48–e48. 2 indexed citations
9.
Gekeler, Volker, Monika Baudler, Luba Benimetskaya, et al.. (2006). G3139 and Other CpG-Containing Immunostimulatory Phosphorothioate Oligodeoxynucleotides Are Potent Suppressors of the Growth of Human Tumor Xenografts in Nude Mice. Oligonucleotides. 16(1). 83–93. 36 indexed citations
10.
Schmidt, Angela, et al.. (2005). Cardiovascular parameters in anaesthetized guinea pigs: A safety pharmacology screening model. Journal of Pharmacological and Toxicological Methods. 52(1). 106–114. 40 indexed citations
11.
Schreiber, S., Peter Scheid, Guido Hanauer, et al.. (2004). The spatial orientation of Helicobacter pylori in the gastric mucus. Proceedings of the National Academy of Sciences. 101(14). 5024–5029. 253 indexed citations
12.
Hanauer, Guido, et al.. (2002). Expression of UreI is required for intragastric transit and colonization of gerbil gastric mucosa by Helicobacter pylori. Research in Microbiology. 153(10). 659–666. 56 indexed citations
13.
Hanauer, Guido, et al.. (2001). Use of a direct H. Pylori antigen detection system in an animal model. Gastroenterology. 120(5). A578–A578. 3 indexed citations
14.
Häfner, D., et al.. (1993). Randomized Placebo-controlled Study on the Characteristics and Duration of Action of Surfactant Treatment in Premature Lambs. Pulmonary Pharmacology. 6(4). 255–262. 1 indexed citations
15.
Beume, Rolf, et al.. (1991). Telenzepine and its enantiomers, M1-selective antimuscarinics, in guinea pig lung function tests.. PubMed. 34. 131–47. 4 indexed citations
16.
Hanauer, Guido, Ulrich Gräf, & Tobias Meißner. (1991). In vivo cytochrome P 450 interactions of the newly developed H+/K(+)-ATPase inhibitor pantoprazole (BY 1023/SK&F 96022) compared to other antiulcer drugs.. PubMed. 13(1). 63–7. 7 indexed citations
17.
Krömer, W., Stefan Postius, R. M. Riedel, et al.. (1990). BY 1023/SK&F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions.. Journal of Pharmacology and Experimental Therapeutics. 254(1). 129–135. 13 indexed citations
18.
Hanauer, Guido. (1990). A new and simple method to test drug interactions with metabolic enzymes of rats in vivo.. PubMed. 12(8). 557–62. 1 indexed citations
19.
Krömer, W., Stefan Postius, R. M. Riedel, et al.. (1990). BY 1023/SK&F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions.. PubMed. 254(1). 129–35. 57 indexed citations
20.
Hanauer, Guido, et al.. (1987). Serum Effects on Thyroxine and Triiodothyronine Levels. Journal of Veterinary Medicine Series A. 34(1-10). 790–797. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas G. Verriere Breakdown of academic impact, for papers by György Miklós Buzás Breakdown of academic impact, for papers by B. Kollberg Breakdown of academic impact, for papers by Christoph von Ritter Breakdown of academic impact, for papers by Jianyi Yin Breakdown of academic impact, for papers by Radosław Kempiński Breakdown of academic impact, for papers by Yuan‐Chieh Yang Breakdown of academic impact, for papers by José Luis Realpe Breakdown of academic impact, for papers by Ami Ben Yaʼacov Breakdown of academic impact, for papers by Stefan Postius
Rankless by CCL
2026